Addus HomeCare (NASDAQ:ADUS) Announces Earnings Results, Beats Expectations By $0.24 EPS

Addus HomeCare (NASDAQ:ADUS) posted its earnings results on Monday. The company reported $1.21 EPS for the quarter, topping the consensus estimate of $0.97 by $0.24, Briefing.com reports. Addus HomeCare had a net margin of 5.91% and a return on equity of 9.70%. The firm had revenue of $280.70 million for the quarter, compared to the consensus estimate of $279.49 million. During the same period in the prior year, the business posted $0.84 earnings per share. The business’s quarterly revenue was up 11.6% on a year-over-year basis.

Addus HomeCare Stock Performance

Addus HomeCare stock opened at $107.09 on Thursday. The firm has a market capitalization of $1.75 billion, a P/E ratio of 26.57, a P/E/G ratio of 1.94 and a beta of 0.96. The stock has a fifty day moving average price of $99.03 and a two-hundred day moving average price of $92.71. Addus HomeCare has a 52-week low of $78.35 and a 52-week high of $107.54. The company has a debt-to-equity ratio of 0.18, a current ratio of 1.38 and a quick ratio of 1.38.

Wall Street Analysts Forecast Growth

ADUS has been the subject of a number of recent analyst reports. Barclays cut Addus HomeCare from an “equal weight” rating to an “underweight” rating and set a $83.00 target price for the company. in a research report on Tuesday, April 23rd. Stephens reiterated an “overweight” rating and issued a $115.00 price objective on shares of Addus HomeCare in a research note on Tuesday. Bank of America upped their price target on Addus HomeCare from $115.00 to $118.00 and gave the stock a “buy” rating in a report on Tuesday. William Blair reiterated an “outperform” rating on shares of Addus HomeCare in a research note on Monday, February 5th. Finally, Oppenheimer reaffirmed an “outperform” rating and set a $118.00 price objective on shares of Addus HomeCare in a research report on Tuesday, March 26th. One research analyst has rated the stock with a sell rating and eight have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $106.57.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.